REFRESH OPTIVE ADVANCED- carboxymethylcellulose sodium, glycerin, and polysorbate 80 solution/ drops 
Allergan, Inc.

----------

Refresh Optive® ADVANCED
Drug Facts

Active ingredients

Carboxymethylcellulose sodium 0.5%

Glycerin 1%

Polysorbate 80 0.5%

Purpose

Eye lubricant

Eye lubricant

Eye lubricant

Uses

Warnings

Stop use and ask a doctor if

you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Instill 1 or 2 drops in the affected eye(s) as needed.

Other information

Inactive ingredients

Boric acid; carbomer copolymer type A; castor oil; erythritol; levocarnitine; purified water; PURITE® (stabilized oxychloro complex); and sodium hydroxide (to adjust pH).

Questions or comments?

1.800.678.1605

refreshbrand.com

v1.0DFL4307

Principal Display Panel

NDC 0023-4307-10

Refresh

Optive®

ADVANCED

Lubricant Eye Drops

TRIPLE-ACTION RELIEF

Clinically proven to lubricate,
hydrate, and protect
natural tears from evaporating

0.33 fl oz (10 mL) Sterile

Principal Display Panel
NDC 0023-4307-10
Refresh
Optive®
ADVANCED
Lubricant Eye Drops
TRIPLE-ACTION RELIEF
Clinically proven to lubricate,
hydrate, and protect
natural tears from evaporating
0.33 fl oz (10 mL) Sterile

Principal Display Panel

NDC 0023-4307-15

Value Size!

Refresh

Optive®

ADVANCED

Lubricant Eye Drops

TRIPLE-ACTION RELIEF

Clinically proven to lubricate,
hydrate, and protect
natural tears from evaporating

0.5 fl oz (15 mL) Sterile

Principal Display Panel
NDC 0023-4307-15
Value Size!
Refresh
Optive®
ADVANCED
Lubricant Eye Drops
TRIPLE-ACTION RELIEF
Clinically proven to lubricate,
hydrate, and protect
natural tears from evaporating
0.5 fl oz (15 mL) Sterile

Principal Display Panel

NDC 0023-4307-02 - Sample

Refresh

Optive®

ADVANCED

Lubricant Eye Drops

TRIPLE-ACTION RELIEF

Clinically proven to lubricate,
hydrate, and protect
natural tears from evaporating

0.068 fl oz (2 mL) Sterile

Principal Display Panel
NDC 0023-4307-02 - Sample
Refresh
Optive®
ADVANCED
Lubricant Eye Drops
TRIPLE-ACTION RELIEF
Clinically proven to lubricate,
hydrate, and protect
natural tears from evaporating
0.068 fl oz (2 mL) Sterile

REFRESH OPTIVE ADVANCED 
carboxymethylcellulose sodium, glycerin, and polysorbate 80 solution/ drops
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0023-4307
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
carboxymethylcellulose sodium (UNII: K679OBS311) (carboxymethylcellulose - UNII:05JZI7B19X) carboxymethylcellulose sodium5 mg  in 1 mL
glycerin (UNII: PDC6A3C0OX) (glycerin - UNII:PDC6A3C0OX) glycerin10 mg  in 1 mL
polysorbate 80 (UNII: 6OZP39ZG8H) (polysorbate 80 - UNII:6OZP39ZG8H) polysorbate 805 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
boric acid (UNII: R57ZHV85D4)  
carbomer copolymer type A (UNII: 71DD5V995L)  
castor oil (UNII: D5340Y2I9G)  
erythritol (UNII: RA96B954X6)  
levocarnitine (UNII: 0G389FZZ9M)  
water (UNII: 059QF0KO0R)  
sodium chlorite (UNII: G538EBV4VF)  
hydrochloric acid (UNII: QTT17582CB)  
sodium hydroxide (UNII: 55X04QC32I)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0023-4307-031 in 1 CARTON11/30/2011
13 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
2NDC:0023-4307-101 in 1 CARTON11/30/2011
210 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
3NDC:0023-4307-202 in 1 CARTON11/30/2011
310 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
4NDC:0023-4307-021 in 1 CARTON11/30/2011
42 mL in 1 BOTTLE; Type 0: Not a Combination Product
5NDC:0023-4307-151 in 1 CARTON11/30/2011
515 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01811/30/2011
Labeler - Allergan, Inc. (144796497)

Revised: 9/2022
Document Id: b6de74b4-5475-4572-8b07-2585e1fac94d
Set id: aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0
Version: 13
Effective Time: 20220913
 
Allergan, Inc.